Gilead Sciences (GILD) Inventory (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Inventory data on file, last reported at $1.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 8.81% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 8.81% YoY), and the FY2025 full-year result was $1.8 billion, up 3.74% from the prior year.
• Inventory for Q1 2026 stood at $1.9 billion, up from $1.8 billion in the prior quarter.
• Across five years, Inventory topped out at $2.0 billion in Q2 2024 and bottomed at $1.5 billion in Q3 2022.
• The 5-year median for Inventory is $1.8 billion (2025), against an average of $1.7 billion.
• The widest annual swing landed in 2022, when Inventory retreated 16.69%; it then climbed 24.07% in 2024.
• A 5-year view of Inventory shows it stood at $1.5 billion in 2022, then gained by 18.58% to $1.8 billion in 2023, then decreased by 4.31% to $1.7 billion in 2024, then gained by 3.74% to $1.8 billion in 2025, then advanced by 7.89% to $1.9 billion in 2026.
• The last three Inventory figures came in at $1.9 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison